GOLDSTEIN DOV A MD - 18 Aug 2025 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
18 Aug 2025
Net transactions value
+$19,137
Form type
4
Filing time
19 Aug 2025, 16:01:23 UTC
Previous filing
25 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GOLDSTEIN DOV A MD Director 5850 SAN FELIPE ST., SUITE 500, HOUSTON, /s/ David Snyder, Attorney-in-Fact 19 Aug 2025 0001120478

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COYA Common Stock, par value $0.0001 per share Options Exercise $19,137 +17,557 +176% $1.09 27,557 18 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Options Exercise $0 -17,557 -100% $0.000000 0 18 Aug 2025 Common Stock 17,557 $1.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested.